We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,143 results
  1. Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation

    Methylation of the promoters of SHOX2 and RASSF1A (LungMe®) exhibits promise as a potential molecular biomarker for diagnosing lung cancer. This...

    Jian Liu, Tingting Bian, ... Yifei Liu in BMC Cancer
    Article Open access 02 March 2024
  2. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma

    Background The methylation of SHOX2 and RASSF1A shows promise as a potential biomarker for the early screening of lung cancer, offering a solution to...

    Jia** Zhao, Yu Lu, ... Honggang Ke in BMC Cancer
    Article Open access 05 June 2024
  3. Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma

    Background

    RAS association domain family protein 1A ( RASSF1A ) promoter hypermethylation is suggested to be linked to hepatocellular carcinoma (HCC),...

    Gang Xu, **aoxiang Zhou, ... Yilei Mao in Cancer Cell International
    Article Open access 10 November 2020
  4. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma

    The Ras association domain family 1 isoform A ( RASSF1A ), cytotoxic T lymphocyte antigen 4 ( CTLA-4 ), and signal transducer and activator of...

    Nermin A. Ali, Nadia M. Hamdy, ... Hala O. EL Mesallamy in Archives of Virology
    Article 01 April 2021
  5. Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival

    Background

    There is strong evidence that disease progression, drug response and overall clinical outcomes of CML disease are not only decided by...

    Sameer Ahmad Guru, Mamta Pervin Sumi, ... Alpana Saxena in BMC Cancer
    Article Open access 14 April 2022
  6. Hypermethylation of Gene Promoters in Blood Leukocytes of Irradiated Individuals—Final Research Results

    Abstract

    Hypermethylation of CpG islands in the promoter regions of four genes ( p53 , ATM , SOD3 , ESR1 ) was studied in blood leukocytes of irradiated...

    N. S. Kuzmina, N. Sh. Lapteva, A. V. Rubanovich in Russian Journal of Genetics
    Article 11 November 2022
  7. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review

    Patients diagnosed with epithelial ovarian cancer (OC) have a 5-year survival rate of 49%. For early-stage disease, the 5-year survival rate is above...

    Simone Karlsson Terp, Malene Pontoppidan Stoico, ... Inge Søkilde Pedersen in Clinical Epigenetics
    Article Open access 14 February 2023
  8. High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas

    Background

    HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) are sensitive to chemo-radiation therapy and have favorable survival outcomes...

    Yoshikuni Inokawa, Masamichi Hayashi, ... Mohammad O. Hoque in BMC Cancer
    Article Open access 07 November 2022
  9. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

    Background

    RASSF1A, a tumor suppressor gene, is frequently inactivated in lung cancer leading to a YAP-dependent epithelial-mesenchymal transition...

    Maureen Keller, Fatéméh Dubois, ... Guénaëlle Levallet in Journal of Experimental & Clinical Cancer Research
    Article Open access 12 April 2019
  10. Role of MST1 in the regulation of autophagy and mitophagy: implications for aging-related diseases

    As a key mechanism to maintain cellular homeostasis under stress conditions, autophagy/mitophagy is related to the occurrence of metabolic disorders,...

    Huayu Shang, Trisha A. VanDusseldorp, ... Zhi **a in Journal of Physiology and Biochemistry
    Article 21 June 2022
  11. The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer

    Background

    High-risk human papillomavirus (HR-HPV) infection is the main cause of cervical cancer, but additional alterations are necessary for its...

    Jaqueline Loaeza-Loaeza, Berenice Illades-Aguiar, ... Daniel Hernández-Sotelo in Clinical Epigenetics
    Article Open access 06 January 2022
  12. Gene Methylation in Circulating Cell-Free DNA from the Blood Plasma as Prognostic and Predictive Factor in Breast Cancer

    Abstract

    Despite considerable progress in the early-stage diagnostics and treatment of breast cancer (BC), there is a high chance of recurrence. The...

    S. V. Rykov, E. A. Filippova, ... E. A. Braga in Russian Journal of Genetics
    Article 18 November 2021
  13. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine

    The intestinal neoplastic transformation is a possible risk of chronic inflammatory bowel disease (IBD). Previous evidence in mice IBD provides a...

    Pinelopi Nterma, Eleni Panopoulou, ... Martha Assimakopoulou in Pathology & Oncology Research
    Article 02 January 2019
  14. Urine DNA biomarkers for hepatocellular carcinoma screening

    Background

    Hepatocellular carcinoma (HCC) occurs in a well-defined high-risk patient population, but better screening tests are needed to improve...

    Amy K. Kim, James P. Hamilton, ... Ying-Hsiu Su in British Journal of Cancer
    Article 19 January 2022
  15. Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis

    Background

    Upregulation of the mitogen-activated protein kinase (MAPK) cascade is common in hepatocellular carcinoma (HCC). Neuroblastoma RAS viral...

    Sophie Klemm, Katja Evert, ... Alexander Scheiter in BMC Cancer
    Article Open access 09 November 2023
  16. Nierenzellkarzinome

    Dieses Kapitel stellt die molekularen Mechanismen in einigen der vielen verschiedenen Tumorarten heraus, die in der erwachsenen Niere entstehen....
    Chapter 2024
  17. Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects

    Pancreatic cancer is one of the most challenging cancers due to its high mortality rates. Considering the late diagnosis and the limited survival...

    María Victoria García-Ortiz, Pablo Cano-Ramírez, ... Antonio Rodríguez-Ariza in Biomarker Research
    Article Open access 05 October 2023
  18. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer

    Lung cancer (LC) is the main cause of cancer-related mortality. Most LC patients are diagnosed in an advanced stage when the symptoms are obvious,...

    Peilong Li, Shibiao Liu, ... Chuanxin Wang in Clinical Epigenetics
    Article Open access 24 September 2022
  19. Liquid Biopsy in Hepatocellular Carcinoma

    Hepatocellular carcinoma (HCC) is one of the most deadly neoplasms with a poor prognosis. Due to the significant tumor heterogeneity of HCC,...
    Zheyu Zhou, **aoliang Xu, ... Yin Yin in Liquid Biopsies
    Protocol 2023
  20. Molecular Pathogenesis of Lung Cancer: Evolving Landscapes Based on Past Experience

    Lung cancers are characterized by abundant genetic diversity with relatively few recurrent mutations occurring at high frequency. However, genetic...
    Parul Sharma, Siddharth Sharma, Ranbir Chander Sobti in Molecular Biomarkers for Cancer Diagnosis and Therapy
    Chapter 2024
Did you find what you were looking for? Share feedback.